PR Newswire Clinical TrialsOriginal article
Peer-Reviewed Study Validates First Blood Test for Early-Stage Breast Cancer Detection
Data ReadoutpositiveBlood test for early-stage breast cancer detectionPositive
AI Analysis
Summary
Astrin Biosciences published a peer-reviewed study demonstrating that its blood test for early-stage breast cancer detection achieved >92% sensitivity and specificity, exceeding current supplemental screening standards.
Outcome Details
peer-reviewed study reports >92% sensitivity and specificity, outperforming current standards for supplemental screening
Importance:6/10
Sentiment:
0.75
blood testbreast cancerearly detectionproteomicspeer-revieweddiagnostic
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 30, 2026 2:35 PM